Hybrigenics gets French approval for Phase II psoriasis drug trial - Pharmaceutical Business Review

Hybrigenics gets Gallic approval for Phase 2 psoriasis drug trial medicine Business Review Hybrigenics has received AFSSAPS, the Gallic drug agency approval for initiating a double-blinded and placebo-controlled Phase II legal proceeding to evaluate oral inecalcitol in patients with disease of the skin . The study faculty evaluate 40 patients with inecalcitol ... Hybrigenics gets approval and funding for a Phase II clinical trial of ... PharmaLive (press release) (subscription) each 2 news articles » Link To Article